Search results
Results from the WOW.Com Content Network
Namwandi also served as IUM's vice-chancellor from 2001 until he was appointed deputy Minister of Education in 2010. [5] The IUM vice-chancellor position was taken over by Namwandi's wife, Virginia. In 2002 IUM it was accorded university status. It opened another campus in the Dorado Park neighbourhood of Windhoek in April 2011.
Mweshipandeka High School is a school in Ongwediva in the Oshana region of northern Namibia.It is one of the well known schools in the country, and is located in the center of Ongwediva, in Libertina Amadhila street, next to Kleine Kuppe Private School and the International University of Management.
Founded in 1986, the International University of Monaco (IUM) (French: Université internationale de Monaco) is located in the Principality of Monaco.It offers undergraduate and graduate degrees in business specialized in finance, marketing, sport business management and international management, taught in English.
Ongwediva is a town in the Oshana Region in the north of Namibia. It is the district capital of the Ongwediva electoral constituency. As of 2023 it had 28,000 inhabitants and covered 4,102 hectares of land. Ongwediva has seven churches, two private schools and 13 government-run schools. Most of the inhabitants speak Oshiwambo. [4]
The Ongwediva College of Education (OCE) was one of four pedagogical colleges in Namibia. It offered three-year undergraduate diploma courses in basic vocational education to elementary and high school teachers: the Basic Education Teacher Diploma (BETD). [1] The college was based in Ongwediva town, founded in 1913 by Finnish missionaries. In ...
IOM's main aid measures include shelter, protection, the provision of basic medical and sanitary care, life safety, coordination, telecommunications and logistics. On the instructions of the UN Emergency Relief Coordinator, IOM, together with UNHCR, is primarily responsible for camp coordination and management in humanitarian emergencies. [12]
The US Food and Drug Administration (FDA) granted approval in March 2015, [15] [24] and the European Medicines Agency (EMA) approved it in October 2015. [10] [7] [8] In 2017, Basilea licensed rights to Pfizer to market isavuconazole in Europe and other regions. [25] [26] [27]